Skip to main content
. 2011 Jan 26;31(6):1387–1393. doi: 10.1038/jcbfm.2011.4

Figure 1.

Figure 1

Glutamate serum levels at admission versus mRS score. The higher glutamate levels at admission corresponded to higher mRS scores at 3 months. Panel A corresponds to development cohort, whereas panel B represents data obtained from the validation cohort. Glutamate levels are shown as mean±s.d. mRS, modified Rankin Scale.